SOPHiA GENETICS is proud to participate in the 70th Anniversary of the SBG Congress, taking place in Belém, Brazil, in 2025. As a global leader in data-driven medicine, we are thrilled to engage with the genetics and healthcare communities at this landmark event.
📍 Visit us at Booth #5
Our team will be on-site to showcase how SOPHiA GENETICS is transforming complex genomic data into actionable insights—empowering clinicians and researchers worldwide.
Discover the New Generation SOPHiA DDM™ Platform
Explore our most recent innovations in Exome Sequencing, and learn how they are advancing the diagnosis and resolution of complex genetic cases.
Save the date! Corporate Workshop
Date: August 15
Time: 1:00 pm - 2:00 pm
Hangar 2 Room
Title: Unraveling Complex Genetic Disorders via Exome Sequencing
Speakers:
Dra. Ilana Zalcberg Renault, Onco-hematologist, Dasa GenĂ´mica
Bruno Piovezan, Subject Matter Expert, SOPHiA GENETICS

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.